Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028754 (
obesity
)
124,988
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Introduction
. Increase in body weight is a gradual process that usually begins in childhood and in adolescence as a result of multiple interactions among environmental and genetic factors. This study aimed to analyze the relationship between copy number variants (CNVs) in five genes and four intergenic regions with
obesity
in Mexican children.
Methods
. We studied 1423 children aged 6-12 years. Anthropometric measurements and blood levels of biochemical parameters were obtained. Identification of CNVs was performed by real-time PCR. The effect of CNVs on
obesity
or body composition was assessed using regression models adjusted for age, gender, and family history of
obesity
.
Results
. Gains in copy numbers of
LEPR
and
NEGR1
were associated with decreased body mass index (BMI), waist circumference (WC), and risk of abdominal obesity, whereas gain in
ARHGEF4
and
CPXCR1
and the intergenic regions 12q15c, 15q21.1a, and 22q11.21d and losses in
INS
were associated with increased BMI and WC.
Conclusion
. Our results indicate a possible contribution of CNVs in
LEPR
,
NEGR1
,
ARHGEF4
, and
CPXCR1
and the intergenic regions 12q15c, 15q21.1a, and 22q11.21d to the development of
obesity
, particularly abdominal obesity in Mexican children.
...
PMID:Copy Number Variations in Candidate Genes and Intergenic Regions Affect Body Mass Index and Abdominal Obesity in Mexican Children. 2842 59